Pyoderma Gangrenosum Associated with Sunitinib: A Case Report

dc.contributor.authors	Dikicier, BS;
dc.date.accessioned	2020-02-27T08:28:53Z
dc.date.available	2020-02-27T08:28:53Z
dc.date.issued	2019
dc.identifier.citation	Dikicier, BS; (2019). Pyoderma Gangrenosum Associated with Sunitinib: A Case Report. ADVANCES IN SKIN & WOUND CARE, 32, 429-427
dc.identifier.issn	1527-7941
dc.identifier.uri	https://doi.org/10.1097/01.ASW.0000577128.03996.95
dc.identifier.uri	https://hdl.handle.net/20.500.12619/66099
dc.description.abstract	Pyoderma gangrenosum (PG) is an inflammatory neutrophilic dermatosis that presents with painful, sterile ulcers. Drug-induced PG is a rare condition; propylthiouracil, granulocyte colony-stimulating factor, and sunitinib are drugs that have been implicated to date. This article presents a case of PG associated with sunitinib.
dc.language	English
dc.publisher	LIPPINCOTT WILLIAMS & WILKINS
dc.subject	Surgery
dc.title	Pyoderma Gangrenosum Associated with Sunitinib: A Case Report
dc.type	Editorial Material
dc.identifier.volume	32
dc.identifier.startpage	427
dc.identifier.endpage	429
dc.contributor.department	Sakarya Üniversitesi/Tıp Fakültesi/Dahili Tıp Bilimleri Bölümü
dc.contributor.saüauthor	Sevimli Dikicier, Bahar
dc.relation.journal	ADVANCES IN SKIN & WOUND CARE
dc.identifier.wos	WOS:000482962400007
dc.identifier.doi	10.1097/01.ASW.0000577128.03996.95
dc.identifier.eissn	1538-8654
dc.contributor.author	Sevimli Dikicier, Bahar